Atossa Therapeutics (ATOS) Ratios
Atossa Therapeutics Ratios
MX:ATOS's free cash flow for Q2 2026 was $-9.64M. For the 2026 fiscal year, MX:ATOS's free cash flow was increased by $0.00 and operating cash flow was $-9.64M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.53 | 14.99 | 17.61 | 21.23 | 45.18 |
| Quick Ratio | 5.53 | 14.99 | 17.33 | 20.29 | 45.18 |
| Cash Ratio | 5.00 | 14.31 | 16.89 | 19.92 | 43.63 |
| Solvency Ratio | -4.21 | -5.13 | -5.74 | -4.84 | -6.58 |
| Operating Cash Flow Ratio | -3.61 | -4.23 | -4.00 | -3.73 | -5.27 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 37.36M | $ 69.49M | $ 86.98M | $ 112.63M | $ 138.11M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.21 | 1.07 | 1.06 | 1.05 | 1.02 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 1.19 | 2.79 | 2.82 | 4.01 | 6.65 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 93.62% | 92.34% | 95.91% | 97.36% | 100.41% |
| Return on Assets (ROA) | -73.03% | -33.36% | -31.27% | -21.82% | -14.59% |
| Return on Equity (ROE) | -88.35% | -35.68% | -33.06% | -22.85% | -14.92% |
| Return on Capital Employed (ROCE) | -94.38% | -38.64% | -34.47% | -23.47% | -14.86% |
| Return on Invested Capital (ROIC) | -94.38% | -38.64% | -34.47% | -23.47% | -14.86% |
| Return on Tangible Assets | -73.03% | -33.36% | -31.27% | -21.82% | -14.59% |
| Earnings Yield | -45.62% | -21.47% | -1.81% | -2.68% | -0.73% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.03 | 0.03 | 0.00 | 0.01 |
| Inventory Turnover | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -14578.53 | 10807.17 | 104116.25 | -27248.04 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 23598.04 | 239394.38 | 0.00 |
| Days of Payables Outstanding | 0.00 | 14578.53 | 12790.87 | 135278.13 | 27248.04 |
| Operating Cycle | 0.00 | 0.00 | 23598.04 | 239394.38 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.46 | -2.51 | -0.17 | -0.16 | -0.14 |
| Free Cash Flow Per Share | -3.46 | -2.51 | -0.17 | -0.16 | -0.14 |
| Dividend Paid and CapEx Coverage Ratio | -1294.00 | -1106.84 | -1495.79 | -768.89 | -1830.22 |
| Capital Expenditure Coverage Ratio | -1294.00 | -1106.84 | -1495.79 | -768.89 | -1830.22 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -39.08% | -17.72% | -1.26% | -2.06% | -0.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.19 | -4.72 | -55.30 | -37.34 | -136.21 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.94 | 1.66 | 18.29 | 8.53 | 20.32 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.56 | -5.64 | -79.42 | -48.43 | -170.31 |
| Price-to-Operating Cash Flow Ratio | -2.56 | -5.65 | -79.47 | -48.49 | -170.40 |
| Price-to-Earnings Growth (PEG) Ratio | -0.06 | 0.28 | -3.87 | -2.24 | 1.50 |
| Enterprise Value Multiple | -1.00 | -1.87 | -50.26 | -32.36 | -130.28 |
| Enterprise Value | 34.91M | 47.73M | 1.58B | 895.77M | 2.67B |
| EV to EBITDA | -1.00 | -1.87 | -50.26 | -32.36 | -130.28 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -1.17 | -2.27 | -75.20 | -43.09 | -162.03 |
| EV to Operating Cash Flow | -1.17 | -2.27 | -75.25 | -43.15 | -162.12 |
| Tangible Book Value Per Share | 4.57 | 8.52 | 0.72 | 0.93 | 1.18 |
| Shareholders’ Equity Per Share | 4.57 | 8.52 | 0.72 | 0.93 | 1.18 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -4.04 | -3.04 | -0.24 | -0.21 | -0.18 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.96 | 0.97 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.86 | 0.82 | 0.70 | 0.77 | 0.80 |
Currency in USD